phase 2_completion
saveCancer Institute and Hospital Chinese Academy of Medical Sciences — lenvatinib (Phase II Trial Completion)
community read0 votes
Therapy area: Cardiovascular, Oncology. Indication: Hepatocellular Carcinoma, Thrombosis, Venous (Vein) Thrombosis
Data sources
globaldata
Found something off?
same company · ±60 days · 1
related news · 1
🐶 often sniffed alongside
top 8- tagOncology20 co-mentions · 3 sources
- companyEisai Co Ltd2 co-mentions · 2 sources
- tagInfectious Disease2 co-mentions · 2 sources
- tagBreast Cancer2 co-mentions · 2 sources
- tagColorectal Cancer2 co-mentions · 2 sources
- tagMelanoma2 co-mentions · 2 sources
- druglenvatinib mesylate2 co-mentions · 2 sources
- companyCancer Institute and Hospital Chinese Academy of Medical Sciences1 co-mentions · 1 sources
comments(0)
5-min edit window · permanent after that